Literature DB >> 11837989

Homocysteine and atherothrombosis.

E Falk1, J Zhou, J Møller.   

Abstract

Atherosclerosis with or without thrombosis superimposed is the most frequent cause of ischemic heart disease (IHD), peripheral arterial disease, and a main cause of stroke. Conflicting results have been reported in genetic, observational, and experimental studies on the relationship between homocysteine and these atherothrombotic diseases. Although cardiovascular complications are common in homocystinuric patients (severe hyperhomocysteinemia), IHD, the most frequent manifestation of atherothrombosis in the general population, appears to be rare. On the basis of findings in individuals with hyperhomocysteinemia of genetic origin, there is in fact no clear evidence for a causal role of homocysteine in the pathogenesis of atherothrombotic disease, and the positive association between plasma homocysteine and IHD observed in many, but not all epidemiologic studies does not prove causality. To infer causality from observational studies, there should be a temporal, consistent, strong, independent, graded (dose-response effect), and duration-dependent relationship between exposure and outcomes, and a biologically plausible mechanism should exist. The relationship between plasma homocysteine levels and IHD does not fulfill these criteria beyond reasonable doubt. In the general population, plasma homocysteine levels are to a great extent determined by dietary habits, and plasma homocysteine could be a marker, or a consequence, of atherothrombosis and/or risk-associated behavior (e.g., a diet low in fruits and vegetables) rather than a cause of atherothrombosis. Experimentally, hyperhomocysteinemia is not in itself atherogenic in normal animals with relatively low plasma cholesterol levels. The homocysteine theory of atherosclerosis should be tested more thoroughly in hypercholesterolemic animals that develop atherosclerosis spontaneously to determine whether elevated plasma homocysteine levels are harmful under atherogenic conditions. A causal role of homocysteine in atherothrombotic disease remains to be established.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11837989     DOI: 10.1007/s11745-001-0676-x

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  81 in total

Review 1.  Homocysteine metabolism.

Authors:  J Selhub
Journal:  Annu Rev Nutr       Date:  1999       Impact factor: 11.848

2.  Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects.

Authors:  J C Chambers; O A Obeid; J S Kooner
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

3.  Failure to produce atherosclerosis in Macaca radiata on a high-methionine, high-fat, pyridoxine-deficient diet.

Authors:  K Krishnaswamy; S B Rao
Journal:  Atherosclerosis       Date:  1977-07       Impact factor: 5.162

4.  Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.

Authors:  K Robinson; K Arheart; H Refsum; L Brattström; G Boers; P Ueland; P Rubba; R Palma-Reis; R Meleady; L Daly; J Witteman; I Graham
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

Review 5.  Homocysteine and cardiovascular disease: cause or effect?

Authors:  L Brattström; D E Wilcken
Journal:  Am J Clin Nutr       Date:  2000-08       Impact factor: 7.045

6.  Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells.

Authors:  A Majors; L A Ehrhart; E H Pezacka
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

7.  Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.

Authors:  M Watanabe; J Osada; Y Aratani; K Kluckman; R Reddick; M R Malinow; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons.

Authors:  L A Harker; J M Harlan; R Ross
Journal:  Circ Res       Date:  1983-12       Impact factor: 17.367

9.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

10.  PATHOLOGICAL FINDINGS IN HOMOCYSTINURIA.

Authors:  J B GIBSON; N A CARSON; D W NEILL
Journal:  J Clin Pathol       Date:  1964-07       Impact factor: 3.411

View more
  6 in total

1.  Failure of vitamin supplementation to lower the risk of recurrent stroke.

Authors:  Harold P Adams
Journal:  Curr Neurol Neurosci Rep       Date:  2011-02       Impact factor: 5.081

2.  Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?

Authors:  Wesley E Stites; Jeffrey W Froude
Journal:  Med Hypotheses       Date:  2006-10-24       Impact factor: 1.538

3.  Prevalence and correlative factors of hyperhomocysteinemia in elderly patients with femoral neck fracture: A cross-sectional study.

Authors:  Kun Tao; Ming Li; Jing Ling; Yiji Tu
Journal:  J Clin Lab Anal       Date:  2022-06-17       Impact factor: 3.124

4.  Novel Clinical Evidence of an Association between Homocysteine and Insulin Resistance in Patients with Hypothyroidism or Subclinical Hypothyroidism.

Authors:  Ning Yang; Zhi Yao; Li Miao; Jia Liu; Xia Gao; Hui Fan; Yanjin Hu; Heng Zhang; Yuan Xu; Aijuan Qu; Guang Wang
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 5.  Homocysteine-Lowering Interventions in Chronic Kidney Disease.

Authors:  Shirinsadat Badri; Sahar Vahdat; Shiva Seirafian; Morteza Pourfarzam; Tahereh Gholipur-Shahraki; Sara Ataei
Journal:  J Res Pharm Pract       Date:  2021-12-25

6.  Apoptosis of bone marrow mesenchymal stem cells caused by homocysteine via activating JNK signal.

Authors:  Benzhi Cai; Xingda Li; Yang Wang; Yanju Liu; Fan Yang; Hongyang Chen; Kun Yin; Xueying Tan; Jiuxin Zhu; Zhenwei Pan; Baoqiu Wang; Yanjie Lu
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.